Epidemiology and risk factors for clostridium difficile infection in children

Pediatric Infectious Disease Journal

Volumn 30, Issue 7, 2011, Pages 580-584

  Sandora, Thomas J ^a   Fung, Monica ^b   Flaherty, Kathleen ^a   Helsing, Laura ^a   Scanlon, Patricia ^a   Potter Bynoe, Gail ^a   Gidengil, Courtney A ^a,c   Lee, Grace M ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RAND CORPORATION   (United States)

^d HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

Author keywords

Clostridium difficile; epidemiology; pediatrics; risk factors

Indexed keywords

ANTIBIOTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE;

ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTROTOMY; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; JEJUNOSTOMY; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 79959687178     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31820bfb29     Document Type: Article

References (42)

1. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-2441. (Pubitemid 41770164)
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442-2449. (Pubitemid 41770165)
3. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-.2005. Emerg Infect Dis. 2008;14:929-931. (Pubitemid 351838602)
4. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis. 2007; 13:1417-1419. (Pubitemid 47510317)
5. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis. 2010;16:604-609.
6. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficilerelated hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J. 2008;27:1111-1113.
7. Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics. 2008;122:1266-1270.
8. Benson L, Song X, Campos J, et al. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol. 2007;28:1233-1235. (Pubitemid 47596560)
9. Centers for Disease Control and Prevention. Surveillance for communityassociated Clostridium difficile-Connecticut, 2006. Morb Mortal Wkly Rep. 2008;57:340-343.
10. Vaishnavi C. Established and potential risk factors for Clostridum difficile infection. Indian J Med Microbiol. 2009;27:289-300.
11. DuPont HL, Garey K, Caeiro JP, et al. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008;21:500-507.
12. Dial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-2995. (Pubitemid 41817660)
13. Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170:784-790.
14. Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16:197-204.
15. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205-210. (Pubitemid 351158048)
16. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345-351. (Pubitemid 46401531)
17. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339-344. (Pubitemid 46401530)
18. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28:140-145. (Pubitemid 46374153)
19. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-1260. (Pubitemid 41532667)
20. Al-Jumaili IJ, Shibley M, Lishman AH, et al. Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol. 1984;19:77-78. (Pubitemid 14213309)
21. Larson HE, Barclay FE, Honour P, et al. Epidemiology of Clostridium difficile in infants. J Infect Dis. 1982;146:727-733. (Pubitemid 13211868)
22. McFarland LV, Brandmarker SA, Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gastroenterol Nutr. 2000;31:220-231.
23. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.
24. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med. 2009;151:176-179.
25. Bacon AE, Fekety R, Schaberg DR, et al. Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system. J Infect Dis. 1988;158:349-354.
26. Matsuki S, Ozaki E, Shozu M, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol. 2005;8:43-48. (Pubitemid 43126754)
27. Stark PL, Lee A, Parsonage BD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun. 1982;35:895-899.
28. Tina LG, Proto N, Sciacca A. Asymptomatic intestinal colonization by Clostridium difficile in preterm neonates. Pediatr Infect Dis J. 1994;13: 1158-1159. (Pubitemid 24376784)
29. Tullus K, Aronsson B, Marcus S, et al. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis. 1989;8:390-393. (Pubitemid 19142004)
30. Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J. 2009;28:145-146.
31. Owens RC Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(suppl 1):S19-S31. (Pubitemid 351323662)
32. Sharma AK, Holder FE. Clostridium difficile diarrhea after use of tacrolimus following renal transplantation. Clin Infect Dis. 1998;27:1540-1541. (Pubitemid 29242443)
33. Gunderson CC, Gupta MR, Lopez F, et al. Clostridium difficile colitis in lung transplantation. Transpl Infect Dis. 2008;10:245-251. (Pubitemid 352040436)
34. Wong NA, Bathgate AJ, Bellamy CO. Colorectal disease in liver allograft recipients-a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol. 2002;14:231-236. (Pubitemid 34259270)
35. Bobak D, Arfons LM, Creger RJ, et al. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant. 2008;42:705-713.
36. Theunissen C, Knoop C, Nonhoff C, et al. Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation. Transpl Infect Dis. 2008;10:240-244. (Pubitemid 352040425)
37. Castagnola E, Battaglia T, Bandettini R, et al. Clostridium difficile-associated disease in children with solid tumors. Support Care Cancer. 2009;17: 321-324.
38. Kamthan AG, Bruckner HW, Hirschman SZ, et al. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med. 1992;152: 1715-1717.
39. Dial S, Delaney JA, Schneider V, et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ. 2006;175:745-748. (Pubitemid 44520987)
40. Linsky A, Gupta K, Lawler EV, et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170:772-778.
41. Bliss DZ, Johnson S, Savik K, et al. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129:1012-1019. (Pubitemid 29005824)
42. Centers for Disease Control and Prevention. Severe Clostridium difficileassociated disease in populations previously at low risk-4 states, 2005. Morb Mortal Wkly Rep. 2005;54:1201-1205.